OTCPK:OCPNY (Japan) Also Trade In: Germany Japan USA

Olympus Corp $ 18.85 -0.23 (-1.22%)

Volume:
1,139
Avg Vol (1m):
13,125
Market Cap $:
24.85 Bil
Enterprise Value $:
25.94 Bil
P/E (TTM):
52.01
P/B:
7.17
Warning! GuruFocus has detected 1 Severe warning sign with OCPNY. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

OCPNY News and Headlines - Olympusrp

GuruFocus Articles Total 11
  • 1

Discussion of markets and holdings

As [url=https://www.gurufocus.com/StockBuy.php?GuruName=David+Herro]David Herro[/url] ([url=https://www.gurufocus.com/StockBuy.php?GuruName=David+Herro]Trades[/url], [url=https://www.gurufocus.com/holdings.php?GuruName=David+Herro]Portfolio[/url]) wrote in his lead letter, it was a difficult quarter for global markets and the Oakmark International Fund was not exempt. The Fund declined 38.1% for the quarter ended March 31, compared to the MSCI World ex U.S. Index, which lost 23.3%. Since the Fund’s inception in September 1992, it has returned an average of 7.4% per year. The top contributor for the quarter was Olympus (TSE:7733) (Japan), while the largest detractor was Glencore (LSE:GLEN) (Switzerland). Over the course of the past six months, the top contributor was Ferguson (LSE:FERG) (U.K.), while the largest

55 Views    Sydnee Gatewood    2020-04-08 16:56
FPA Crescent Fund manager reports 2nd-quarter portfolio, sells Axalta and Alcoa

FPA Crescent Fund’s Steven Romick (Trades, Portfolio) reported his second-quarter portfolio on Thursday, showing that he bought two stocks and exited two of his positions.

Romick runs the FPA Crescent Fund along with two colleagues and has built it to $15 billion in assets. Founded in 1993, the fund may invest in both equity and debt, and sometimes sells securities short, such as its current bet against the SPDR S&P Regional Banking (KRE). Primarily, it seeks stocks of large and small market capitalizations that have low valuations and attractive future prospects based on fundamental security analysis.

The

1607 Views    Holly LaFon    2019-07-11 21:36
Guru invested in Scottish bank and Japanese manufacturer in 3rd quarter

David Herro (Trades, Portfolio), manager of the Oakmark International Fund, acquired two new holdings and sold another in the third quarter.

Herro has managed the Oakmark International Fund since its inception in 1992. He also manages the Oakmark International Small Cap Fund and the Oakmark Global Select Fund. The fund seeks long-term capital appreciation in foreign stocks. Herro buys businesses that are trading at a discount to their intrinsic values, are expected to grow shareholder value over time and have management teams that act as owners.

The investor purchased 140,225,000 shares of The Royal Bank of Scotland

286 Views    Sydnee Gatewood    2016-12-13 17:03
Guru stock highlight

We also initiated a position in Olympus (TSE:7733), the Japanese camera and endoscopes company, during the quarter. We owned Olympus in the past and most recently sold our shares in February 2016 as it approached our estimate of intrinsic value. However, by mid-August the share price had fallen over 30%, and since our investment thesis was intact, we repurchased the name into the Fund.

From [url=http://www.gurufocus.com/StockBuy.php?GuruName=David+Herro]David Herro[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=David+Herro]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=David+Herro]Portfolio[/url])'s Oakmark International Fund third quarter 2016 commentary.

390 Views    Holly LaFon    2016-10-10 18:36
Review of holdings and quarter

The Oakmark International Fund returned 7% for the fiscal year ended September 30, 2016, nearly matching the MSCI World ex U.S. Index, which returned just over 7%. For the most recent quarter, the Fund outperformed the MSCI World ex U.S. Index, returning 13% versus 6%. Additionally, the Fund has performed well versus the MSCI World ex U.S. Index since its September 1992 inception, returning an average of 9% versus 6% over the same period.

Glencore (LSE:GLEN), one of the world’s largest mining companies and commodities traders, was the top contributor to performance for the fiscal period and the

457 Views    Holly LaFon    2016-10-10 18:32

Another top contributor was Olympus (TSE:7733), the world leader in endoscopes and other medical equipment, which returned 18% over the past twelve months. Management continues to invest in the medical business with a focus on growth in surgery. Olympus is the dominant player in the gastrointestinal space, but the company is a relative newcomer to surgery. Olympus plans to enlarge its sales staff and enhance its research and development capabilities in the surgical business. Management believes the medical segment will grow 10% this year, driven by higher sales in surgery in addition to endoscope growth in the emerging world.

611 Views    Vera Yuan    2014-10-07 22:19

The Oakmark International Fund declined 1% for the fiscal year ended September 30, 2014, underperforming the MSCI World ex U.S. Index, which gained 5%. For the most recent quarter the Fund also underperformed the MSCI World ex U.S. Index, declining 7% versus a decline of 6%. However, the Fund has performed well versus the MSCI World ex U.S. Index since its September 1992 inception, returning an average of 11% versus 6% over the same period.

Intesa Sanpaolo (MIL:ISP), an Italian retail and commercial bank, was the top contributor to performance over the past 12 months, returning 50%. Intesa’s share

1193 Views    Vera Yuan    2014-10-07 21:13
The [url=http://www.gurufocus.com/StockBuy.php?GuruName=T.+Rowe+Price+Japan+Fund]T. Rowe Price Japan Fund[/url] has $264.14 million in net assets and has returned 25.27% year to date. Since inception in 1991 it has returned 1.31%. There are 95 positions in the portfolio, of which 19 are new in the second quarter, for 26% quarter-over-quarter turnover. The largest of the new positions include: Olympus Corporation (TSE:7733), SECOM Co. Ltd. (TSE:9735), Toyota Industries Corp (TSE:6201), Suntory Beverage & Food Ltd. (TSE:2587) and Sumitomo Corp. (TSE:8053). [b]New Buys[/b] [b]Sumitomo Corp. (TSE:8053)[/b] The fund bought 182,000 shares of Sumitomo Corp. for 1,254 yen in the second quarter, equal to 0.89% of the
352 Views    Holly LaFon    2013-07-17 21:23
Another large contributor to performance for the quarter was Olympus (TSE:7733), a world leader in endoscopes and other medical equipment, which returned 22%. Its medical systems group designs and manufactures clinical analyzers and other imaging devices. Olympus also makes products such as binoculars, microscopes, measuring equipment, printers, barcode scanners and magneto-optical disk drives, as well as traditional cameras. The share price rallied early in the quarter after Bank of Japan Governor Masaaki Shirakawa indicated the central bank would pursue monetary easing, which stands to benefit export-oriented companies. Share prices also rallied after Olympus announced plans to cut interest-bearing debt by
186 Views    Holly LaFon    2013-04-23 16:44
The Oakmark International Fund returned 5.4% for the quarter ended March 31, 2013, outperforming the MSCI World ex U.S. Index, which returned 4.7% over the same period. For the first six months of the Fund’s fiscal year, the Fund returned 20%, which outperformed the MSCI World ex U.S. Index’s 11% return. Since its inception in September 1992, the Fund has returned an average of 11% per year, outperforming the MSCI World ex U.S. Index, which has averaged 6% per year over the same period. For the second straight quarter, Daiwa Securities, Japan’s second-largest brokerage, was the largest contributor to performance.
673 Views    Holly LaFon    2013-04-23 16:28
Olympus Corp. (OCPNY) and three of its former executives pleaded guilty this week to charges related to a $1.7 billion accounting cover-up, [url=http://www.chinapost.com.tw/business/company-focus/2012/09/26/355565/Olympus-former.htm]the[/url] [url=http://www.nytimes.com/2012/09/26/business/global/guilty-pleas-in-trial-over-olympus-scandal.html?_r=1]media[/url] [url=http://professional.wsj.com/article/SB10000872396390444813104578017262175684182.html?mg=reno64-wsj]reported[/url]. During the year since the Japanese equipment maker's former CEO Michael C. Woodford raised questions about its deal-making, Olympus has made some improvements to its corporate governance, but continues to show serious weaknesses that interfere with its ability to balance the powers of its managers. To be sure, it’s positive that the former chairman Tsuyoshi Kikukawa, executive vice president Hisashi Mori, and internal auditor Hideo Yamada no longer manage the company. They reportedly face up
267 Views    GMI Ratings    2012-09-28 16:25